Integrating Siloed Systems – Making The Most Of Automation

By moving to a more automated approach, pharma can take advantage of many benefits, including consistent quality, reduced manual interactions and human errors, the potential to scale quickly, improved responsiveness, lowered costs and increased reliability. Along with analytics, artificial intellige...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical Processing
Main Author Quinn, Rory
Format Trade Publication Article
LanguageEnglish
Published Rockaway Advantage Business Media 19.12.2017
Subjects
Artificial intelligence
Automation
Big Data
Cost control
Human error
Legacy systems
Pharmaceutical industry
Productivity
R&D
Research & development
Value chain
Online AccessGet full text

Cover

More Information
Summary:By moving to a more automated approach, pharma can take advantage of many benefits, including consistent quality, reduced manual interactions and human errors, the potential to scale quickly, improved responsiveness, lowered costs and increased reliability. Along with analytics, artificial intelligence (AI) and machine learning (ML), big data is part of a broader wave of technology sweeping through the industry that could lead to the ultimate form of automation. When looking to the future, the only certainty is that the volumes of data being produced through the Pharma R&D value chain is going to rise – and the technology that allows data to be interrogated and lead to new breakthroughs will also continue to develop at pace.
ISSN:1049-9156